nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR1—multiple sclerosis	0.809	1	CbGaD
Nabilone—CNR2—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.00903	0.0944	CbGpPWpGaD
Nabilone—CNR1—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.00708	0.074	CbGpPWpGaD
Nabilone—Dronabinol—CNR1—multiple sclerosis	0.00581	1	CrCbGaD
Nabilone—CNR2—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.00457	0.0477	CbGpPWpGaD
Nabilone—CNR2—Small Ligand GPCRs—CNR1—multiple sclerosis	0.00396	0.0414	CbGpPWpGaD
Nabilone—CNR1—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.00358	0.0374	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—KCNA3—multiple sclerosis	0.00231	0.0242	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Other—S1PR1—multiple sclerosis	0.00202	0.0211	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—LINGO1—multiple sclerosis	0.00185	0.0193	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00121	0.0126	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.00103	0.0107	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Other—CXCR3—multiple sclerosis	0.000988	0.0103	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00096	0.01	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000947	0.0099	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000903	0.00944	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00089	0.0093	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00089	0.0093	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000826	0.00863	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000805	0.00842	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000774	0.00808	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000753	0.00787	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000731	0.00764	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000709	0.0074	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000708	0.00739	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000708	0.00739	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000698	0.0073	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000698	0.0073	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000648	0.00677	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Other—CCR5—multiple sclerosis	0.000619	0.00647	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000607	0.00634	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00059	0.00616	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GPR65—multiple sclerosis	0.000589	0.00616	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000574	0.00599	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000573	0.00599	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000566	0.00592	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000555	0.0058	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000555	0.0058	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000547	0.00572	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCR1—multiple sclerosis	0.000539	0.00563	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000539	0.00563	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000532	0.00556	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000529	0.00553	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000504	0.00527	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—BDNF—multiple sclerosis	0.000497	0.00519	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000491	0.00513	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000485	0.00507	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000477	0.00498	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000469	0.0049	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.000463	0.00483	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GPR65—multiple sclerosis	0.000462	0.00483	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000456	0.00477	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00045	0.0047	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000445	0.00465	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SPP1—multiple sclerosis	0.000441	0.00461	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000429	0.00449	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR1—multiple sclerosis	0.000423	0.00442	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000423	0.00442	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000421	0.0044	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000418	0.00436	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000413	0.00432	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00041	0.00429	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000396	0.00413	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL3—multiple sclerosis	0.000384	0.00401	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000381	0.00398	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000379	0.00396	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000375	0.00392	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000374	0.00391	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00037	0.00386	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00037	0.00386	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000368	0.00384	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000358	0.00374	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000357	0.00373	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000351	0.00367	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCR2—multiple sclerosis	0.000347	0.00363	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000343	0.00358	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000333	0.00348	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000326	0.00341	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000324	0.00339	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000322	0.00336	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CNR1—multiple sclerosis	0.00032	0.00335	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RGS1—multiple sclerosis	0.000319	0.00333	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000305	0.00318	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000305	0.00318	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GPR65—multiple sclerosis	0.000302	0.00316	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL3—multiple sclerosis	0.000301	0.00315	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000297	0.00311	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000294	0.00308	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000294	0.00307	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LINGO1—multiple sclerosis	0.000292	0.00306	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00029	0.00303	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00029	0.00303	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—POMC—multiple sclerosis	0.000289	0.00302	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000289	0.00302	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00028	0.00293	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR1—multiple sclerosis	0.000277	0.00289	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000277	0.00289	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000276	0.00288	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR2—multiple sclerosis	0.000272	0.00285	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000269	0.00281	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000261	0.00273	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000256	0.00267	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TAGAP—multiple sclerosis	0.000254	0.00265	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RGS1—multiple sclerosis	0.00025	0.00262	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL5—multiple sclerosis	0.000248	0.0026	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000239	0.0025	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000239	0.0025	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000237	0.00248	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000231	0.00241	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00023	0.0024	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000229	0.0024	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000227	0.00237	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000226	0.00237	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000225	0.00235	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCR5—multiple sclerosis	0.000224	0.00234	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—S1PR1—multiple sclerosis	0.000222	0.00232	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000217	0.00227	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000217	0.00227	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GPC5—multiple sclerosis	0.000216	0.00225	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000209	0.00218	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—STAT3—multiple sclerosis	0.000209	0.00218	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000202	0.00211	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000199	0.00208	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000197	0.00206	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000196	0.00205	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL5—multiple sclerosis	0.000195	0.00204	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00019	0.00198	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK1—multiple sclerosis	0.00019	0.00198	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RGS1—multiple sclerosis	0.000188	0.00197	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000183	0.00191	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000181	0.00189	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00018	0.00188	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GPR65—multiple sclerosis	0.000179	0.00187	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000178	0.00186	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000176	0.00184	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000176	0.00183	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—POMC—multiple sclerosis	0.000175	0.00183	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000174	0.00182	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000171	0.00179	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GPC5—multiple sclerosis	0.000169	0.00177	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CNR1—multiple sclerosis	0.000164	0.00172	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000164	0.00171	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000163	0.00171	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR1—multiple sclerosis	0.000163	0.00171	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000163	0.0017	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000158	0.00165	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000155	0.00162	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000154	0.00161	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000149	0.00156	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000148	0.00155	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RGS1—multiple sclerosis	0.000148	0.00154	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000144	0.0015	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00014	0.00147	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GPR65—multiple sclerosis	0.00014	0.00146	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR2—multiple sclerosis	0.00014	0.00146	CbGpPWpGaD
Nabilone—Convulsion—Triamcinolone—multiple sclerosis	0.000139	0.00155	CcSEcCtD
Nabilone—Tachycardia—Prednisolone—multiple sclerosis	0.000139	0.00155	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000139	0.00155	CcSEcCtD
Nabilone—Convulsion—Methylprednisolone—multiple sclerosis	0.000139	0.00155	CcSEcCtD
Nabilone—Hypertension—Triamcinolone—multiple sclerosis	0.000138	0.00155	CcSEcCtD
Nabilone—Hypertension—Methylprednisolone—multiple sclerosis	0.000138	0.00154	CcSEcCtD
Nabilone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000138	0.00154	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—POMC—multiple sclerosis	0.000137	0.00143	CbGpPWpGaD
Nabilone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000137	0.00153	CcSEcCtD
Nabilone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000137	0.00153	CcSEcCtD
Nabilone—Myalgia—Triamcinolone—multiple sclerosis	0.000137	0.00153	CcSEcCtD
Nabilone—Vomiting—Azathioprine—multiple sclerosis	0.000136	0.00153	CcSEcCtD
Nabilone—Myalgia—Methylprednisolone—multiple sclerosis	0.000136	0.00152	CcSEcCtD
Nabilone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000136	0.00152	CcSEcCtD
Nabilone—Eye disorder—Prednisone—multiple sclerosis	0.000136	0.00152	CcSEcCtD
Nabilone—Anxiety—Methylprednisolone—multiple sclerosis	0.000136	0.00152	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—multiple sclerosis	0.000136	0.00151	CcSEcCtD
Nabilone—Rash—Azathioprine—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Dermatitis—Azathioprine—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Depression—Methotrexate—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Flushing—Prednisone—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Discomfort—Triamcinolone—multiple sclerosis	0.000135	0.00151	CcSEcCtD
Nabilone—Discomfort—Methylprednisolone—multiple sclerosis	0.000135	0.0015	CcSEcCtD
Nabilone—Headache—Azathioprine—multiple sclerosis	0.000134	0.0015	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000134	0.0014	CbGpPWpGaD
Nabilone—Dry mouth—Triamcinolone—multiple sclerosis	0.000134	0.00149	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—multiple sclerosis	0.000132	0.00148	CcSEcCtD
Nabilone—Confusional state—Methylprednisolone—multiple sclerosis	0.000132	0.00147	CcSEcCtD
Nabilone—Malaise—Betamethasone—multiple sclerosis	0.000131	0.00147	CcSEcCtD
Nabilone—Malaise—Dexamethasone—multiple sclerosis	0.000131	0.00147	CcSEcCtD
Nabilone—Vertigo—Dexamethasone—multiple sclerosis	0.000131	0.00146	CcSEcCtD
Nabilone—Vertigo—Betamethasone—multiple sclerosis	0.000131	0.00146	CcSEcCtD
Nabilone—Syncope—Betamethasone—multiple sclerosis	0.00013	0.00146	CcSEcCtD
Nabilone—Syncope—Dexamethasone—multiple sclerosis	0.00013	0.00146	CcSEcCtD
Nabilone—Arrhythmia—Prednisone—multiple sclerosis	0.00013	0.00145	CcSEcCtD
Nabilone—Infection—Triamcinolone—multiple sclerosis	0.00013	0.00145	CcSEcCtD
Nabilone—Infection—Methylprednisolone—multiple sclerosis	0.00013	0.00145	CcSEcCtD
Nabilone—Shock—Triamcinolone—multiple sclerosis	0.000129	0.00144	CcSEcCtD
Nabilone—Insomnia—Prednisolone—multiple sclerosis	0.000129	0.00144	CcSEcCtD
Nabilone—Shock—Methylprednisolone—multiple sclerosis	0.000128	0.00144	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR1—multiple sclerosis	0.000128	0.00134	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000128	0.00134	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000128	0.00134	CbGpPWpGaD
Nabilone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Paraesthesia—Prednisolone—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Tachycardia—Triamcinolone—multiple sclerosis	0.000128	0.00143	CcSEcCtD
Nabilone—Nausea—Azathioprine—multiple sclerosis	0.000127	0.00142	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000127	0.00133	CbGpPWpGaD
Nabilone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000127	0.00142	CcSEcCtD
Nabilone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000127	0.00141	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000126	0.00132	CbGpPWpGaD
Nabilone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000126	0.00141	CcSEcCtD
Nabilone—Convulsion—Dexamethasone—multiple sclerosis	0.000126	0.00141	CcSEcCtD
Nabilone—Convulsion—Betamethasone—multiple sclerosis	0.000126	0.00141	CcSEcCtD
Nabilone—Hypertension—Dexamethasone—multiple sclerosis	0.000126	0.0014	CcSEcCtD
Nabilone—Hypertension—Betamethasone—multiple sclerosis	0.000126	0.0014	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000125	0.0013	CbGpPWpGaD
Nabilone—Asthenia—Mitoxantrone—multiple sclerosis	0.000124	0.00139	CcSEcCtD
Nabilone—Myalgia—Betamethasone—multiple sclerosis	0.000124	0.00138	CcSEcCtD
Nabilone—Myalgia—Dexamethasone—multiple sclerosis	0.000124	0.00138	CcSEcCtD
Nabilone—Anxiety—Betamethasone—multiple sclerosis	0.000123	0.00138	CcSEcCtD
Nabilone—Anxiety—Dexamethasone—multiple sclerosis	0.000123	0.00138	CcSEcCtD
Nabilone—Discomfort—Dexamethasone—multiple sclerosis	0.000122	0.00137	CcSEcCtD
Nabilone—Discomfort—Betamethasone—multiple sclerosis	0.000122	0.00137	CcSEcCtD
Nabilone—Hypotension—Methylprednisolone—multiple sclerosis	0.000122	0.00136	CcSEcCtD
Nabilone—Pain—Prednisolone—multiple sclerosis	0.000122	0.00136	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—multiple sclerosis	0.000121	0.00135	CcSEcCtD
Nabilone—Vision blurred—Prednisone—multiple sclerosis	0.000119	0.00134	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000119	0.00133	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000119	0.00133	CcSEcCtD
Nabilone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000119	0.00133	CcSEcCtD
Nabilone—Insomnia—Triamcinolone—multiple sclerosis	0.000118	0.00132	CcSEcCtD
Nabilone—Insomnia—Methylprednisolone—multiple sclerosis	0.000118	0.00132	CcSEcCtD
Nabilone—Infection—Betamethasone—multiple sclerosis	0.000118	0.00132	CcSEcCtD
Nabilone—Infection—Dexamethasone—multiple sclerosis	0.000118	0.00132	CcSEcCtD
Nabilone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000118	0.00131	CcSEcCtD
Nabilone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000118	0.00131	CcSEcCtD
Nabilone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Anaemia—Prednisone—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Shock—Betamethasone—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Shock—Dexamethasone—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Nabilone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000117	0.0013	CcSEcCtD
Nabilone—Agitation—Prednisone—multiple sclerosis	0.000116	0.0013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCL3—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000116	0.00121	CbGpPWpGaD
Nabilone—Tachycardia—Betamethasone—multiple sclerosis	0.000116	0.0013	CcSEcCtD
Nabilone—Tachycardia—Dexamethasone—multiple sclerosis	0.000116	0.0013	CcSEcCtD
Nabilone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000115	0.00129	CcSEcCtD
Nabilone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000115	0.00129	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000115	0.0012	CbGpPWpGaD
Nabilone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000115	0.00128	CcSEcCtD
Nabilone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000115	0.00128	CcSEcCtD
Nabilone—Malaise—Prednisone—multiple sclerosis	0.000114	0.00128	CcSEcCtD
Nabilone—Vertigo—Prednisone—multiple sclerosis	0.000114	0.00127	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—multiple sclerosis	0.000114	0.00127	CcSEcCtD
Nabilone—Syncope—Prednisone—multiple sclerosis	0.000114	0.00127	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—multiple sclerosis	0.000113	0.00127	CcSEcCtD
Nabilone—Anorexia—Betamethasone—multiple sclerosis	0.000113	0.00127	CcSEcCtD
Nabilone—Anorexia—Dexamethasone—multiple sclerosis	0.000113	0.00127	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000113	0.00118	CbGpPWpGaD
Nabilone—Fatigue—Triamcinolone—multiple sclerosis	0.000113	0.00126	CcSEcCtD
Nabilone—Fatigue—Methylprednisolone—multiple sclerosis	0.000113	0.00126	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000112	0.00117	CbGpPWpGaD
Nabilone—Pain—Triamcinolone—multiple sclerosis	0.000112	0.00125	CcSEcCtD
Nabilone—Loss of consciousness—Prednisone—multiple sclerosis	0.000111	0.00125	CcSEcCtD
Nabilone—Hypotension—Dexamethasone—multiple sclerosis	0.000111	0.00124	CcSEcCtD
Nabilone—Hypotension—Betamethasone—multiple sclerosis	0.000111	0.00124	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PGR—multiple sclerosis	0.00011	0.00115	CbGpPWpGaD
Nabilone—Vomiting—Mitoxantrone—multiple sclerosis	0.00011	0.00123	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00011	0.00115	CbGpPWpGaD
Nabilone—Convulsion—Prednisone—multiple sclerosis	0.00011	0.00123	CcSEcCtD
Nabilone—Hypertension—Prednisone—multiple sclerosis	0.000109	0.00122	CcSEcCtD
Nabilone—Rash—Mitoxantrone—multiple sclerosis	0.000109	0.00122	CcSEcCtD
Nabilone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000109	0.00122	CcSEcCtD
Nabilone—Chills—Methotrexate—multiple sclerosis	0.000109	0.00122	CcSEcCtD
Nabilone—Headache—Mitoxantrone—multiple sclerosis	0.000109	0.00121	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CXCR3—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000108	0.00121	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000108	0.00121	CcSEcCtD
Nabilone—Myalgia—Prednisone—multiple sclerosis	0.000108	0.00121	CcSEcCtD
Nabilone—Arthralgia—Prednisone—multiple sclerosis	0.000108	0.00121	CcSEcCtD
Nabilone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000108	0.00121	CcSEcCtD
Nabilone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000108	0.0012	CcSEcCtD
Nabilone—Anxiety—Prednisone—multiple sclerosis	0.000108	0.0012	CcSEcCtD
Nabilone—Insomnia—Betamethasone—multiple sclerosis	0.000107	0.0012	CcSEcCtD
Nabilone—Insomnia—Dexamethasone—multiple sclerosis	0.000107	0.0012	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CD28—multiple sclerosis	0.000107	0.00112	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000107	0.00119	CcSEcCtD
Nabilone—Paraesthesia—Betamethasone—multiple sclerosis	0.000107	0.00119	CcSEcCtD
Nabilone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000107	0.00119	CcSEcCtD
Nabilone—Discomfort—Prednisone—multiple sclerosis	0.000107	0.00119	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR2—multiple sclerosis	0.000105	0.0011	CbGpPWpGaD
Nabilone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000105	0.00117	CcSEcCtD
Nabilone—Dyspepsia—Betamethasone—multiple sclerosis	0.000105	0.00117	CcSEcCtD
Nabilone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000105	0.00117	CcSEcCtD
Nabilone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000103	0.00116	CcSEcCtD
Nabilone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000103	0.00115	CcSEcCtD
Nabilone—Decreased appetite—Betamethasone—multiple sclerosis	0.000103	0.00115	CcSEcCtD
Nabilone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000103	0.00115	CcSEcCtD
Nabilone—Nausea—Mitoxantrone—multiple sclerosis	0.000103	0.00115	CcSEcCtD
Nabilone—Infection—Prednisone—multiple sclerosis	0.000103	0.00115	CcSEcCtD
Nabilone—Back pain—Methotrexate—multiple sclerosis	0.000102	0.00115	CcSEcCtD
Nabilone—Fatigue—Betamethasone—multiple sclerosis	0.000102	0.00114	CcSEcCtD
Nabilone—Fatigue—Dexamethasone—multiple sclerosis	0.000102	0.00114	CcSEcCtD
Nabilone—Shock—Prednisone—multiple sclerosis	0.000102	0.00114	CcSEcCtD
Nabilone—Pain—Betamethasone—multiple sclerosis	0.000102	0.00114	CcSEcCtD
Nabilone—Pain—Dexamethasone—multiple sclerosis	0.000102	0.00114	CcSEcCtD
Nabilone—Tachycardia—Prednisone—multiple sclerosis	0.000101	0.00113	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCL5—multiple sclerosis	0.0001	0.00105	CbGpPWpGaD
Nabilone—Hyperhidrosis—Prednisone—multiple sclerosis	0.0001	0.00112	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—multiple sclerosis	9.98e-05	0.00112	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCR5—multiple sclerosis	9.92e-05	0.00104	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—POMC—multiple sclerosis	9.88e-05	0.00103	CbGpPWpGaD
Nabilone—Anorexia—Prednisone—multiple sclerosis	9.86e-05	0.0011	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—multiple sclerosis	9.83e-05	0.0011	CcSEcCtD
Nabilone—Anaemia—Methotrexate—multiple sclerosis	9.79e-05	0.00109	CcSEcCtD
Nabilone—Feeling abnormal—Dexamethasone—multiple sclerosis	9.79e-05	0.00109	CcSEcCtD
Nabilone—Feeling abnormal—Betamethasone—multiple sclerosis	9.79e-05	0.00109	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.78e-05	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CNR1—multiple sclerosis	9.71e-05	0.00102	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.71e-05	0.00109	CcSEcCtD
Nabilone—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.71e-05	0.00109	CcSEcCtD
Nabilone—Hypersensitivity—Triamcinolone—multiple sclerosis	9.64e-05	0.00108	CcSEcCtD
Nabilone—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.62e-05	0.00108	CcSEcCtD
Nabilone—Malaise—Methotrexate—multiple sclerosis	9.55e-05	0.00107	CcSEcCtD
Nabilone—Vertigo—Methotrexate—multiple sclerosis	9.51e-05	0.00106	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—multiple sclerosis	9.48e-05	0.00106	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.42e-05	0.00105	CcSEcCtD
Nabilone—Dizziness—Prednisolone—multiple sclerosis	9.41e-05	0.00105	CcSEcCtD
Nabilone—Asthenia—Triamcinolone—multiple sclerosis	9.39e-05	0.00105	CcSEcCtD
Nabilone—Body temperature increased—Betamethasone—multiple sclerosis	9.39e-05	0.00105	CcSEcCtD
Nabilone—Body temperature increased—Dexamethasone—multiple sclerosis	9.39e-05	0.00105	CcSEcCtD
Nabilone—Abdominal pain—Dexamethasone—multiple sclerosis	9.39e-05	0.00105	CcSEcCtD
Nabilone—Abdominal pain—Betamethasone—multiple sclerosis	9.39e-05	0.00105	CcSEcCtD
Nabilone—Asthenia—Methylprednisolone—multiple sclerosis	9.37e-05	0.00105	CcSEcCtD
Nabilone—Insomnia—Prednisone—multiple sclerosis	9.35e-05	0.00105	CcSEcCtD
Nabilone—Paraesthesia—Prednisone—multiple sclerosis	9.29e-05	0.00104	CcSEcCtD
Nabilone—Pruritus—Triamcinolone—multiple sclerosis	9.26e-05	0.00104	CcSEcCtD
Nabilone—Cough—Methotrexate—multiple sclerosis	9.24e-05	0.00103	CcSEcCtD
Nabilone—Pruritus—Methylprednisolone—multiple sclerosis	9.24e-05	0.00103	CcSEcCtD
Nabilone—Convulsion—Methotrexate—multiple sclerosis	9.18e-05	0.00103	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCL3—multiple sclerosis	9.13e-05	0.000954	CbGpPWpGaD
Nabilone—Dyspepsia—Prednisone—multiple sclerosis	9.1e-05	0.00102	CcSEcCtD
Nabilone—Chest pain—Methotrexate—multiple sclerosis	9.02e-05	0.00101	CcSEcCtD
Nabilone—Myalgia—Methotrexate—multiple sclerosis	9.02e-05	0.00101	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—multiple sclerosis	9.02e-05	0.00101	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCR5—multiple sclerosis	9.01e-05	0.000942	CbGpPWpGaD
Nabilone—Decreased appetite—Prednisone—multiple sclerosis	8.99e-05	0.001	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—POMC—multiple sclerosis	8.97e-05	0.000938	CbGpPWpGaD
Nabilone—Rash—Prednisolone—multiple sclerosis	8.97e-05	0.001	CcSEcCtD
Nabilone—Dermatitis—Prednisolone—multiple sclerosis	8.96e-05	0.001	CcSEcCtD
Nabilone—Diarrhoea—Methylprednisolone—multiple sclerosis	8.93e-05	0.000999	CcSEcCtD
Nabilone—Fatigue—Prednisone—multiple sclerosis	8.92e-05	0.000997	CcSEcCtD
Nabilone—Headache—Prednisolone—multiple sclerosis	8.92e-05	0.000997	CcSEcCtD
Nabilone—Discomfort—Methotrexate—multiple sclerosis	8.91e-05	0.000996	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IL2RA—multiple sclerosis	8.88e-05	0.000928	CbGpPWpGaD
Nabilone—Constipation—Prednisone—multiple sclerosis	8.84e-05	0.000989	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTGER4—multiple sclerosis	8.79e-05	0.000919	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL2—multiple sclerosis	8.78e-05	0.000918	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL10—multiple sclerosis	8.75e-05	0.000914	CbGpPWpGaD
Nabilone—Confusional state—Methotrexate—multiple sclerosis	8.71e-05	0.000974	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PGR—multiple sclerosis	8.66e-05	0.000905	CbGpPWpGaD
Nabilone—Dizziness—Triamcinolone—multiple sclerosis	8.65e-05	0.000967	CcSEcCtD
Nabilone—Dizziness—Methylprednisolone—multiple sclerosis	8.64e-05	0.000965	CcSEcCtD
Nabilone—Infection—Methotrexate—multiple sclerosis	8.59e-05	0.00096	CcSEcCtD
Nabilone—Feeling abnormal—Prednisone—multiple sclerosis	8.52e-05	0.000953	CcSEcCtD
Nabilone—Asthenia—Betamethasone—multiple sclerosis	8.52e-05	0.000952	CcSEcCtD
Nabilone—Asthenia—Dexamethasone—multiple sclerosis	8.52e-05	0.000952	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CXCR3—multiple sclerosis	8.49e-05	0.000887	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Prednisone—multiple sclerosis	8.46e-05	0.000945	CcSEcCtD
Nabilone—Nausea—Prednisolone—multiple sclerosis	8.45e-05	0.000945	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CD28—multiple sclerosis	8.41e-05	0.000879	CbGpPWpGaD
Nabilone—Pruritus—Dexamethasone—multiple sclerosis	8.4e-05	0.000939	CcSEcCtD
Nabilone—Pruritus—Betamethasone—multiple sclerosis	8.4e-05	0.000939	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—multiple sclerosis	8.36e-05	0.000934	CcSEcCtD
Nabilone—Vomiting—Triamcinolone—multiple sclerosis	8.32e-05	0.00093	CcSEcCtD
Nabilone—Vomiting—Methylprednisolone—multiple sclerosis	8.3e-05	0.000928	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR2—multiple sclerosis	8.26e-05	0.000863	CbGpPWpGaD
Nabilone—Rash—Triamcinolone—multiple sclerosis	8.25e-05	0.000922	CcSEcCtD
Nabilone—Dermatitis—Triamcinolone—multiple sclerosis	8.24e-05	0.000922	CcSEcCtD
Nabilone—Anorexia—Methotrexate—multiple sclerosis	8.24e-05	0.000921	CcSEcCtD
Nabilone—Rash—Methylprednisolone—multiple sclerosis	8.23e-05	0.00092	CcSEcCtD
Nabilone—Dermatitis—Methylprednisolone—multiple sclerosis	8.23e-05	0.00092	CcSEcCtD
Nabilone—Headache—Triamcinolone—multiple sclerosis	8.2e-05	0.000917	CcSEcCtD
Nabilone—Headache—Methylprednisolone—multiple sclerosis	8.18e-05	0.000915	CcSEcCtD
Nabilone—Abdominal pain—Prednisone—multiple sclerosis	8.18e-05	0.000914	CcSEcCtD
Nabilone—Body temperature increased—Prednisone—multiple sclerosis	8.18e-05	0.000914	CcSEcCtD
Nabilone—Diarrhoea—Betamethasone—multiple sclerosis	8.12e-05	0.000908	CcSEcCtD
Nabilone—Diarrhoea—Dexamethasone—multiple sclerosis	8.12e-05	0.000908	CcSEcCtD
Nabilone—Hypotension—Methotrexate—multiple sclerosis	8.08e-05	0.000903	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—TYK2—multiple sclerosis	7.97e-05	0.000833	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.87e-05	0.00088	CcSEcCtD
Nabilone—Dizziness—Dexamethasone—multiple sclerosis	7.85e-05	0.000878	CcSEcCtD
Nabilone—Dizziness—Betamethasone—multiple sclerosis	7.85e-05	0.000878	CcSEcCtD
Nabilone—Insomnia—Methotrexate—multiple sclerosis	7.82e-05	0.000874	CcSEcCtD
Nabilone—Nausea—Triamcinolone—multiple sclerosis	7.77e-05	0.000869	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—multiple sclerosis	7.76e-05	0.000868	CcSEcCtD
Nabilone—Nausea—Methylprednisolone—multiple sclerosis	7.76e-05	0.000867	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—POMC—multiple sclerosis	7.75e-05	0.00081	CbGpPWpGaD
Nabilone—Dyspnoea—Methotrexate—multiple sclerosis	7.71e-05	0.000861	CcSEcCtD
Nabilone—Somnolence—Methotrexate—multiple sclerosis	7.68e-05	0.000859	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CD86—multiple sclerosis	7.65e-05	0.000799	CbGpPWpGaD
Nabilone—Hypersensitivity—Prednisone—multiple sclerosis	7.62e-05	0.000852	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—multiple sclerosis	7.61e-05	0.00085	CcSEcCtD
Nabilone—Vomiting—Dexamethasone—multiple sclerosis	7.55e-05	0.000844	CcSEcCtD
Nabilone—Vomiting—Betamethasone—multiple sclerosis	7.55e-05	0.000844	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCL5—multiple sclerosis	7.53e-05	0.000787	CbGpPWpGaD
Nabilone—Decreased appetite—Methotrexate—multiple sclerosis	7.51e-05	0.00084	CcSEcCtD
Nabilone—Rash—Betamethasone—multiple sclerosis	7.49e-05	0.000837	CcSEcCtD
Nabilone—Rash—Dexamethasone—multiple sclerosis	7.49e-05	0.000837	CcSEcCtD
Nabilone—Dermatitis—Dexamethasone—multiple sclerosis	7.48e-05	0.000836	CcSEcCtD
Nabilone—Dermatitis—Betamethasone—multiple sclerosis	7.48e-05	0.000836	CcSEcCtD
Nabilone—Fatigue—Methotrexate—multiple sclerosis	7.45e-05	0.000833	CcSEcCtD
Nabilone—Headache—Dexamethasone—multiple sclerosis	7.44e-05	0.000832	CcSEcCtD
Nabilone—Headache—Betamethasone—multiple sclerosis	7.44e-05	0.000832	CcSEcCtD
Nabilone—Asthenia—Prednisone—multiple sclerosis	7.42e-05	0.000829	CcSEcCtD
Nabilone—Pain—Methotrexate—multiple sclerosis	7.39e-05	0.000826	CcSEcCtD
Nabilone—Pruritus—Prednisone—multiple sclerosis	7.32e-05	0.000818	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—IL2—multiple sclerosis	7.31e-05	0.000763	CbGpPWpGaD
Nabilone—Feeling abnormal—Methotrexate—multiple sclerosis	7.12e-05	0.000796	CcSEcCtD
Nabilone—Diarrhoea—Prednisone—multiple sclerosis	7.08e-05	0.000791	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.07e-05	0.00079	CcSEcCtD
Nabilone—Nausea—Dexamethasone—multiple sclerosis	7.05e-05	0.000789	CcSEcCtD
Nabilone—Nausea—Betamethasone—multiple sclerosis	7.05e-05	0.000789	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—POMC—multiple sclerosis	7.04e-05	0.000736	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—multiple sclerosis	6.97e-05	0.000729	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—multiple sclerosis	6.89e-05	0.00072	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL10—multiple sclerosis	6.86e-05	0.000717	CbGpPWpGaD
Nabilone—Dizziness—Prednisone—multiple sclerosis	6.84e-05	0.000764	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—multiple sclerosis	6.83e-05	0.000764	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—multiple sclerosis	6.83e-05	0.000764	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR5—multiple sclerosis	6.78e-05	0.000709	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2RA—multiple sclerosis	6.69e-05	0.000699	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—multiple sclerosis	6.63e-05	0.000693	CbGpPWpGaD
Nabilone—Vomiting—Prednisone—multiple sclerosis	6.58e-05	0.000735	CcSEcCtD
Nabilone—Rash—Prednisone—multiple sclerosis	6.52e-05	0.000729	CcSEcCtD
Nabilone—Dermatitis—Prednisone—multiple sclerosis	6.51e-05	0.000728	CcSEcCtD
Nabilone—Headache—Prednisone—multiple sclerosis	6.48e-05	0.000724	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—multiple sclerosis	6.37e-05	0.000712	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—TYK2—multiple sclerosis	6.26e-05	0.000654	CbGpPWpGaD
Nabilone—Asthenia—Methotrexate—multiple sclerosis	6.2e-05	0.000693	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—APOE—multiple sclerosis	6.17e-05	0.000645	CbGpPWpGaD
Nabilone—Nausea—Prednisone—multiple sclerosis	6.14e-05	0.000687	CcSEcCtD
Nabilone—Pruritus—Methotrexate—multiple sclerosis	6.11e-05	0.000684	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CD86—multiple sclerosis	6e-05	0.000627	CbGpPWpGaD
Nabilone—Diarrhoea—Methotrexate—multiple sclerosis	5.91e-05	0.000661	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCL5—multiple sclerosis	5.91e-05	0.000617	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—multiple sclerosis	5.73e-05	0.000599	CbGpPWpGaD
Nabilone—Dizziness—Methotrexate—multiple sclerosis	5.72e-05	0.000639	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CD80—multiple sclerosis	5.58e-05	0.000583	CbGpPWpGaD
Nabilone—Vomiting—Methotrexate—multiple sclerosis	5.5e-05	0.000614	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SPP1—multiple sclerosis	5.47e-05	0.000572	CbGpPWpGaD
Nabilone—Rash—Methotrexate—multiple sclerosis	5.45e-05	0.000609	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—multiple sclerosis	5.44e-05	0.000609	CcSEcCtD
Nabilone—Headache—Methotrexate—multiple sclerosis	5.41e-05	0.000605	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR5—multiple sclerosis	5.32e-05	0.000556	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—multiple sclerosis	5.3e-05	0.000554	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2RA—multiple sclerosis	5.25e-05	0.000548	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—multiple sclerosis	5.21e-05	0.000544	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL2—multiple sclerosis	5.19e-05	0.000542	CbGpPWpGaD
Nabilone—Nausea—Methotrexate—multiple sclerosis	5.13e-05	0.000574	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAPK1—multiple sclerosis	5.08e-05	0.00053	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—multiple sclerosis	4.84e-05	0.000506	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TYK2—multiple sclerosis	4.71e-05	0.000492	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD80—multiple sclerosis	4.38e-05	0.000458	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—multiple sclerosis	4.16e-05	0.000435	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—multiple sclerosis	4.07e-05	0.000425	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK1—multiple sclerosis	3.98e-05	0.000416	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—multiple sclerosis	3.92e-05	0.00041	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—multiple sclerosis	3.9e-05	0.000408	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—multiple sclerosis	3.71e-05	0.000388	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TYK2—multiple sclerosis	3.7e-05	0.000386	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—multiple sclerosis	3.3e-05	0.000345	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—multiple sclerosis	3.08e-05	0.000321	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—multiple sclerosis	3.06e-05	0.00032	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—multiple sclerosis	3.06e-05	0.00032	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—multiple sclerosis	3.06e-05	0.000319	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK1—multiple sclerosis	3e-05	0.000313	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—multiple sclerosis	2.91e-05	0.000304	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—multiple sclerosis	2.59e-05	0.00027	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—multiple sclerosis	2.4e-05	0.000251	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—multiple sclerosis	2.4e-05	0.000251	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK1—multiple sclerosis	2.35e-05	0.000246	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—multiple sclerosis	2.3e-05	0.000241	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—multiple sclerosis	1.81e-05	0.000189	CbGpPWpGaD
